Skip to main content
. Author manuscript; available in PMC: 2015 Dec 25.
Published in final edited form as: Nature. 2015 Jun 10;522(7557):478–481. doi: 10.1038/nature14510

Table 3. Transmission of human prions to transgenic mice homozygous for human PrP V127.

Inoculum
Transmission data
Aetiology Source Code Human PrPSc type* Attack rate Incubation period, (days p.i) Attack rate Incubation period, (days p.i)
Tg183 V127M129/V127M129
Tg190 V127M129/V127M129
kuru I516 T3 VV 0/19 >488-604 0/22 >391-609
kuru I520 T3 VV 0/19 >391-609 0/19 >370-609
kuru I10336 T3 MV 0/21 >405-607 0/24 >463-617
kuru I518 T2 MM 0/12 >439-600 0/13 >432-603
vCJD I342 T4 MM 0/8 >553-605 0/10 >506-604
vCJD I7042 T4 MM 0/11 >522-609 0/14 >446-607
iCJD (GH) I035 T1 MM 0/10 >434-622 0/10 >450-602
sCJD I11058 T1 MM 0/8 >411-609 0/9 >454-612
iCJD (DM) I026 T2 MM 0/9 >381-602 0/8 >516-602
sCJD I7040 T2 MM 0/8 >524-601 0/6 >564-600
sCJD I280 T2 VV 0/9 >532-602 0/9 >425-601
sCJD I278 T2 VV 0/7 >530-602 0/7 >417-601
sCJD I284 T2 MV 0/6 >549-603 0/6 >466-609
sCJD I1478 T2 MV 0/7 >517-602 0/7 >418-617
sCJD I7394 T3 VV 0/8 >500-600 0/8 >600-603
sCJD I764 T3 MV 0/10 >447-602 0/8 >484-607
iCJD (GH) I2651 T3 VV 0/7 >563-606 0/7 >487-599
iCJD (GH) I020 T3 MV 0/6 >546-603 0/6 >572-600

(days p.i), days post inoculation; vCJD, variant CJD; sCJD, sporadic CJD; iCJD, iatrogenic CJD; GH, growth hormone; DM, dura mater

*

According to classification of Hill et al.28

Attack rate is defined as the total of clinically affected and sub-clinically infected mice as a proportion of the number of inoculated mice. Sub-clinical prion infection was assessed by immunoblotting and/or immunohistochemical examination of brain. As no clinical transmission of prion disease was observed the interval between inoculation and death (from either senescence, culling due to inter-current illness or termination of the experiment) is reported as >x-y days.